i-SENS Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
22,443
17,026
18,937
22,655
19,475
Depreciation, Depletion & Amortization
6,289
6,919
7,585
5,830
7,253
Other Funds
-
230
180
368
295
Funds from Operations
23,439
23,079
25,137
29,027
25,029
Changes in Working Capital
7,249
5,952
4,737
16,962
2,781
Net Operating Cash Flow
16,190
17,127
20,401
12,065
22,248
Capital Expenditures
28,903
8,274
13,980
8,592
24,211
Sale of Fixed Assets & Businesses
9
622
1
388
108
Purchase/Sale of Investments
6,060
605
5,695
4,300
700
Net Investing Cash Flow
35,898
8,617
21,007
13,827
27,917
Cash Dividends Paid - Total
-
-
-
-
1,372
Issuance/Reduction of Debt, Net
9,625
6,094
720
3,231
9,017
Net Financing Cash Flow
27,114
6,844
59
3,807
8,190
Net Change in Cash
7,307
15,680
808
2,672
1,838
Free Cash Flow
12,254
9,221
6,762
4,416
1,413
Net Assets from Acquisitions
727
-
26
8,880
1,131
Other Sources
-
663
2,405
58
500
Change in Capital Stock
17,489
520
481
207
250
Exchange Rate Effect
99
326
144
627
683
Other Uses
217
1,023
3,712
1,101
3,883

About i-SENS

View Profile
Address
I Sens Building
Seoul SL 06646
Korea, Republic Of
Employees -
Website http://www.i-sens.co.kr
Updated 09/14/2018
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. Its products include bolld glucose monitoring devices, electrolyte analyzers and cartridges, blood coagulation measuring instrument, connectors, and others. The company was founded by Cha Geun-Sig and Nam Hak-Hyun on May 4, 2000 and is headquartered in Seoul, South Korea.